Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2018

Jun 25, 2018

35221_dirs_2018-06-25_217f1458-b0a1-41c7-a59d-ece48dbd16c5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2018-06-12

Reporting Person: SIROVICH MATTHEW (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 466514 Direct
Common Stock 1414904 Indirect
Common Stock 732000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series S Warrants (right to buy) $0.01 2032-06-30 Common Stock (1199383) Direct
Series Z Warrants (right to buy) $1.60 2024-04-30 Common Stock (458257) Direct
Series Z Warrants (right to buy) $1.60 2024-04-30 Common Stock (857452) Indirect
Series Z Warrants (right to buy) $1.60 2024-04-30 Common Stock (466000) Indirect

Footnotes

F1: Securities of PAVMed Inc. (the "Issuer") held directly by The Sirovich Family Charitable Foundation (the "Sirovich Foundation"). Matthew Sirovich is a Director and President of the Sirovich Foundation and may be deemed to beneficially own the securities of the Issuer held by the Sirovich Foundation.

F2: Securities of the Issuer held directly by The Boomer Fund, L.P. ("Boomer"). Mr. Sirovich is the general partner of Boomer and may be deemed to beneficially own the securities of the Issuer held by Boomer.

F3: The Series S Warrants cannot be exercised if following such exercise Mr. Sirovich would beneficially own greater than 4.75% of the outstanding shares of the Issuer's common stock and therefore none of the Series S Warrants are currently exercisable.

F4: The Series Z Warrants were exercisable upon issuance.